- All sites activated with 38 patients dosed in the potentially pivotal Phase 2 clinical study, FIRCE-1 of...
Ongoing Phase 1 study informed dose selection for CARGO’s currently enrolling, potentially pivotal Phase 2...
– Appointment adds strategic finance and broad operating experience to Board as Company advances potentially...
SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.